Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): A multinational open-label randomised trial

The Lancet

Volumn 384, Issue 9955, 2014, Pages 1673-1683

  Rodger, Marc A ^a,b   Hague, William M ^c   Kingdom, John ^d   Kahn, Susan R ^e   Karovitch, Alan ^f   Sermer, Mathew ^d   Clement, Anne Marie ^b   Coat, Suzette ^g   Chan, Wee Shian ^h   Said, Joanne ⁱ   Rey, Evelyne ^j   Robinson, Sue ^k   Khurana, Rshmi ^l   Demers, Christine ^m   Kovacs, Michael J ⁿ   Solymoss, Susan ^o   Hinshaw, Kim ^p   Dwyer, James ^q   Smith, Graeme ^r   McDonald, Sarah ^s   Newstead Angel, Jill ^t   McLeod, Anne ^u   Khandelwal, Meena ^v   Silver, Robert M ^w   Le Gal, Gregoire ^b,f   Greer, Ian A ^x   Keely, Erin ^b,f   Rosene Montella, Karen ^y   Walker, Mark ^b   Wells, Philip S ^b,f   more..

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d MOUNT SINAI HOSPITAL   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

^g UNIVERSITY OF ADELAIDE   (Australia)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ UNIVERSITY OF MELBOURNE   (Australia)

^j UNIVERSITY OF MONTREAL   (Canada)

^k DALHOUSIE UNIVERSITY   (Canada)

^l UNIVERSITY OF ALBERTA   (Canada)

^m UNIVERSITÉ LAVAL   (Canada)

ⁿ UNIVERSITY OF WESTERN ONTARIO   (Canada)

^o MCGILL UNIVERSITY   (Canada)

^p SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

^q YORK HOSPITAL   (United Kingdom)

^r QUEEN S UNIVERSITY   (Canada)

^s MCMASTER UNIVERSITY   (Canada)

^t UNIVERSITY OF SASKATCHEWAN   (Canada)

^u SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^v Cooper Hospital ^*  (United States)

^w UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^x UNIVERSITY OF LIVERPOOL   (United Kingdom)

^y BROWN UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIBIOTIC AGENT; BLOOD CLOTTING FACTOR 5 LEIDEN; DALTEPARIN; PHOSPHOLIPID ANTIBODY; PROTHROMBIN; FIBRINOLYTIC AGENT;

ABORTION; ADULT; ANTITHROMBIN DEFICIENCY; ARTICLE; ATTRIBUTABLE RISK; BIRTH WEIGHT; BLEEDING; BODY MASS; CHEMOPROPHYLAXIS; CHILD DEATH; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG SAFETY; DRUG USE; ECLAMPSIA; FAMILY HISTORY; FEMALE; GENE MUTATION; GESTATIONAL AGE; HIGH RISK PATIENT; HUMAN; INTENTION TO TREAT ANALYSIS; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MATERNAL AGE; MULTICENTER STUDY; MULTIPLE PREGNANCY; NEWBORN DEATH; OPEN STUDY; PARITY; PHARMACIST; PHLEBITIS; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL CARE; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SMALL FOR DATE INFANT; SPONTANEOUS ABORTION; SYSTOLIC BLOOD PRESSURE; TERTIARY CARE CENTER; THERAPEUTIC ABORTION; THROMBOPHILIA; TREATMENT OUTCOME; TWINS; VENOUS THROMBOEMBOLISM; CHEMICALLY INDUCED; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; EPIDEMIOLOGY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; RISK FACTOR;

ADULT; DALTEPARIN; FEMALE; FIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; RISK FACTORS; THROMBOPHILIA; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84920860792     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60793-5     Document Type: Article

References (45)

1. F Rodeghiero, A Tosetto The epidemiology of inherited thrombophilia: the VITA Project. Vicenza Thrombophilia and Atherosclerosis Project Thromb Haemost 78 1997 636 640
2. JA Heit, CE Kobbervig, AH James, TM Petterson, KR Bailey, LJ Melton 3rd Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study Ann Intern Med 143 2005 697 706
3. A Gerhardt, RE Scharf, MW Beckmann et al. Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium N Engl J Med 342 2000 374 380
4. CJ Berg, HK Atrash, LM Koonin, M Tucker Pregnancy-related mortality in the United States, 1987-1990 Obstet Gynecol 88 1996 161 167
5. Stillbirth Collaborative Research Network Writing Group Causes of death among stillbirths JAMA 306 2011 2459 2468
6. BB van Rijn, LB Hoeks, ML Bots, A Franx, HW Bruinse Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia Am J Obstet Gynecol 195 2006 723 728
7. C van Walraven, M Mamdani, A Cohn, Y Katib, M Walker, MA Rodger Risk of subsequent thromboembolism for patients with pre-eclampsia BMJ 326 2003 791 792
8. AF Jacobsen, FE Skjeldestad, PM Sandset Ante- and postnatal risk factors of venous thrombosis: a hospital-based case-control study J Thromb Haemost 6 2008 905 912
9. I Pabinger, H Grafenhofer, A Kaider et al. Preeclampsia and fetal loss in women with a history of venous thromboembolism Arterioscler Thromb Vasc Biol 21 2001 874 879
10. MA Rodger, MT Betancourt, P Clark et al. The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies PLoS Med 7 2010 e1000292
11. E Rey, SR Kahn, M David, I Shrier Thrombophilic disorders and fetal loss: a meta-analysis Lancet 361 2003 901 908
12. MJ Kupferminc, A Eldor, N Steinman et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy N Engl J Med 340 1999 9 13
13. SM Bates, IA Greer, S Middeldorp, DL Veenstra, AM Prabulos, PO Vandvik VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2 suppl 2012 e691S e736S
14. IA Greer, C Nelson-Piercy Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy Blood 106 2005 401 407
15. BJ Hunt, HA Doughty, G Majumdar et al. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies Thromb Haemost 77 1997 39 43
16. MS Kramer, RW Platt, SW Wen the Fetal/Infant Health Study Group of the Canadian Perinatal Surveillance System A new and improved population-based Canadian reference for birth weight for gestational age Pediatrics 108 2001 E35
17. S Schulman, C Kearon the Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 2005 692 694
18. PW Friederich, BJ Sanson, P Simioni et al. Frequency of pregnancy-related venous thromboembolism in anticoagulant factor-deficient women: implications for prophylaxis Ann Intern Med 125 1996 955 960
19. RT Lie, S Rasmussen, H Brunborg, HK Gjessing, E Lie-Nielsen, LM Irgens Fetal and maternal contributions to risk of pre-eclampsia: population based study BMJ 316 1998 1343 1347
20. BM Sibai, M Ewell, RJ Levine the The Calcium for Preeclampsia Prevention (CPEP) Study Group Risk factors associated with preeclampsia in healthy nulliparous women Am J Obstet Gynecol 177 1997 1003 1010
21. MA Rodger, D Makropoulos, M Walker, E Keely, A Karovitch, PS Wells Participation of pregnant women in clinical trials: will they participate and why? Am J Perinatol 20 2003 69 76
22. B Brenner Antithrombotic prophylaxis for women with thrombophilia and pregnancy complications - Yes J Thromb Haemost 1 2003 2070 2072
23. CJ Lockwood Inherited thrombophilias in pregnant patients: detection and treatment paradigm Obstet Gynecol 99 2002 333 341
24. AJ Duhl, MJ Paidas, SH Ural et al. Antithrombotic therapy and pregnancy: consensus report and recommendations for prevention and treatment of venous thromboembolism and adverse pregnancy outcomes Am J Obstet Gynecol 197 2007 457.e1 457.e21
25. F Lussana, F Dentali, R Abbate the Italian Society for Haemostasis and Thrombosis Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) Thromb Res 124 2009 e19 e25
26. B Brenner, R Hoffman, H Carp, M Dulitsky, J Younis the LIVE-ENOX Investigators Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study J Thromb Haemost 3 2005 227 229
27. E Grandone, V Brancaccio, D Colaizzo et al. Preventing adverse obstetric outcomes in women with genetic thrombophilia Fertil Steril 78 2002 371 375
28. MJ Kupferminc, G Fait, A Many et al. Low-molecular-weight heparin for the prevention of obstetric complications in women with thrombophilias Hypertens Pregnancy 20 2001 35 44
29. G Huhle, M Geberth, U Hoffmann, DL Heene, J Harenberg Management of heparin-associated thrombocytopenia in pregnancy with subcutaneous r-hirudin Gynecol Obstet Invest 49 2000 67 69
30. J Lepercq, J Conard, A Borel-Derlon et al. Venous thromboembolism during pregnancy: a retrospective study of enoxaparin safety in 624 pregnancies BJOG 108 2001 1134 1140
31. J Visser, VM Ulander, FM Helmerhorst et al. Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia. HABENOX: a randomised multicentre trial Thromb Haemost 105 2011 295 301
32. SP Kaandorp, M Goddijn, JA van der Post et al. Aspirin plus heparin or aspirin alone in women with recurrent miscarriage N Engl J Med 362 2010 1586 1596
33. P Clark, ID Walker, P Langhorne the Scottish Pregnancy Intervention Study (SPIN) collaborators SPIN (Scottish Pregnancy Intervention) study: a multicenter, randomized controlled trial of low-molecular-weight heparin and low-dose aspirin in women with recurrent miscarriage Blood 115 2010 4162 4167
34. M Dolitzky, A Inbal, Y Segal, A Weiss, B Brenner, H Carp A randomized study of thromboprophylaxis in women with unexplained consecutive recurrent miscarriages Fertil Steril 86 2006 362 366
35. CA Laskin, KA Spitzer, CA Clark et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial J Rheumatol 36 2009 279 287
36. J-C Gris, E Mercier, I Quéré et al. Low-molecular-weight heparin versus low-dose aspirin in women with one fetal loss and a constitutional thrombophilic disorder Blood 103 2004 3695 3699
37. M Fawzy, T Shokeir, M El-Tatongy, O Warda, AA El-Refaiey, A Mosbah Treatment options and pregnancy outcome in women with idiopathic recurrent miscarriage: a randomized placebo-controlled study Arch Gynecol Obstet 278 2008 33 38
38. AM Badawy, M Khiary, LS Sherif, M Hassan, A Ragab, I Abdelall Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology J Obstet Gynaecol 28 2008 280 284
39. MA Rodger, M Carrier, G Le Gal the Low-Molecular-Weight Heparin for Placenta-Mediated Pregnancy Complications Study Group Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications Blood 123 2014 822 828
40. JIP de Vries, MG van Pampus, WM Hague, PD Bezemer, JH Joosten the FRUIT Investigators Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT J Thromb Haemost 10 2012 64 72
41. E Rey, P Garneau, M David et al. Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial J Thromb Haemost 7 2009 58 64
42. I Martinelli, P Ruggenenti, I Cetin the HAPPY Study Group Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial Blood 119 2012 3269 3275
43. G Mello, E Parretti, C Fatini et al. Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women Hypertension 45 2005 86 91
44. JC Gris, C Chauleur, N Molinari et al. Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia. The pilot randomised controlled NOH-PE trial Thromb Haemost 106 2011 1053 1061
45. JC Gris, C Chauleur, JL Faillie et al. Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae. The pilot randomised controlled NOH-AP trial Thromb Haemost 104 2010 771 779